Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class ASSE: 603168

Announcement on Obtaining Notice of Approval for Drug Clinical Trial of Phenylephrine and Ketorolac Solution

· Issued by Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trial of Phenylephrine and Ketorolac Solution

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment